Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinji Hadano

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Methods in Enzymology|February 14, 2006
Purification and functional analyses of ALS2 and its homologueShinji Hadano, Joh-E Ikeda
Neurology Research International|August 2, 2012
Dysregulation of the autophagy-endolysosomal system in amyotrophic lateral sclerosis and related motor neuron diseasesAsako Otomo, Lei Pan, Shinji Hadano
Drug Discovery Today|August 18, 2024
Preclinical alternative drug discovery programs for monogenic rare diseases. Should small molecules or gene therapy be used? The case of hereditary spastic paraplegiasMatteo Rossi Sebastiano, Shinji Hadano, Fabrizia Cesca, et al.
Drug Discovery Today|December 27, 2021
AI-based protein structure databases have the potential to accelerate rare diseases research: AlphaFoldDB and the case of IAHSP/AlsinMatteo Rossi Sebastiano, Giuseppe Ermondi, Shinji Hadano, et al.
Neuroscience Research|April 2, 2011
Loss of glial fibrillary acidic protein marginally accelerates disease progression in a SOD1(H46R) transgenic mouse model of ALSYasuhiro Yoshii, Asako Otomo, Lei Pan, et al.
Plos One|October 11, 2017
A novel function of N-linked glycoproteins, alpha-2-HS-glycoprotein and hemopexin: Implications for small molecule compound-mediated neuroprotectionTakuya Kanno, Kaori Yasutake, Kazunori Tanaka, et al.
FEBS Letters|February 9, 2011
Defective relocalization of ALS2/alsin missense mutants to Rac1-induced macropinosomes accounts for loss of their cellular function and leads to disturbed amphisome formationAsako Otomo, Ryota Kunita, Kyoko Suzuki-Utsunomiya, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|July 1, 2026
The SQSTM1 L341V Variant Associated With Sporadic ALS Promotes the Accumulation of Enlarged Ubiquitin-Positive SQSTM1 BodiesKento Shimakura, Akira Oka, Haruka Yudahira, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 25, 2015
Six SQSTM1 mutations in a Chinese amyotrophic lateral sclerosis cohortYi Yang, Lu Tang, Nan Zhang, et al.
Biochemical and Biophysical Research Communications|July 9, 2021
The N-terminal intrinsically disordered region mediates intracellular localization and self-oligomerization of ALS2Kento Shimakura, Kai Sato, Shun Mitsui, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Methods in Enzymology|February 14, 2006
Purification and functional analyses of ALS2 and its homologueShinji Hadano, Joh-E Ikeda
Neurology Research International|August 2, 2012
Dysregulation of the autophagy-endolysosomal system in amyotrophic lateral sclerosis and related motor neuron diseasesAsako Otomo, Lei Pan, Shinji Hadano
Drug Discovery Today|August 18, 2024
Preclinical alternative drug discovery programs for monogenic rare diseases. Should small molecules or gene therapy be used? The case of hereditary spastic paraplegiasMatteo Rossi Sebastiano, Shinji Hadano, Fabrizia Cesca, et al.
Drug Discovery Today|December 27, 2021
AI-based protein structure databases have the potential to accelerate rare diseases research: AlphaFoldDB and the case of IAHSP/AlsinMatteo Rossi Sebastiano, Giuseppe Ermondi, Shinji Hadano, et al.
Neuroscience Research|April 2, 2011
Loss of glial fibrillary acidic protein marginally accelerates disease progression in a SOD1(H46R) transgenic mouse model of ALSYasuhiro Yoshii, Asako Otomo, Lei Pan, et al.
Plos One|October 11, 2017
A novel function of N-linked glycoproteins, alpha-2-HS-glycoprotein and hemopexin: Implications for small molecule compound-mediated neuroprotectionTakuya Kanno, Kaori Yasutake, Kazunori Tanaka, et al.
FEBS Letters|February 9, 2011
Defective relocalization of ALS2/alsin missense mutants to Rac1-induced macropinosomes accounts for loss of their cellular function and leads to disturbed amphisome formationAsako Otomo, Ryota Kunita, Kyoko Suzuki-Utsunomiya, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|July 1, 2026
The SQSTM1 L341V Variant Associated With Sporadic ALS Promotes the Accumulation of Enlarged Ubiquitin-Positive SQSTM1 BodiesKento Shimakura, Akira Oka, Haruka Yudahira, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 25, 2015
Six SQSTM1 mutations in a Chinese amyotrophic lateral sclerosis cohortYi Yang, Lu Tang, Nan Zhang, et al.
Biochemical and Biophysical Research Communications|July 9, 2021
The N-terminal intrinsically disordered region mediates intracellular localization and self-oligomerization of ALS2Kento Shimakura, Kai Sato, Shun Mitsui, et al.
Pageof 6